Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases

Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases

US Patent 10106597 · Granted Oct 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Biomimetic peptide and biodegradable delivery platform for the treatment of angi2024
Methods for identifying and preparing pharmaceutical agents for activating Tie1 2023
Methods for identifying and preparing pharmaceutical agents for activating Tie1 2023
Artificial intelligence reasoning system2023
Mimetic peptides derived from collagen type IV and their use for treating angiog2021
Mimetic peptides derived from collagen type IV and their use for treating angiog2021
Mimetic peptides derived from collagen type IV and their use for treating angiog2021
Mimetic peptides derived from collagen type IV and their use for treating angiog2021
Mimetic peptides derived from collagen type IV and their use for treating angiog2021
Mimetic peptides derived from collagen type IV and their use for treating angiog2021
Peptide inhibitors of tight junction permeability2021